Progyny (NASDAQ:PGNY) Issues Q4 Earnings Guidance

Progyny (NASDAQ:PGNY) updated its fourth quarter earnings guidance on Tuesday. The company provided EPS guidance of $0.07-0.10 for the period, compared to the consensus EPS estimate of $0.14. The company issued revenue guidance of $266.2-281.2 million, compared to the consensus revenue estimate of $292.69 million. Progyny also updated its FY 2024 guidance to 1.540-1.570 EPS.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on PGNY shares. Leerink Partners reduced their price target on shares of Progyny from $25.00 to $21.00 and set a “market perform” rating on the stock in a research note on Thursday, September 19th. Canaccord Genuity Group downgraded shares of Progyny from a “buy” rating to a “hold” rating and dropped their price target for the company from $37.00 to $24.00 in a research note on Wednesday, August 7th. BTIG Research downgraded Progyny from a “buy” rating to a “neutral” rating in a report on Wednesday, August 7th. Jefferies Financial Group reduced their target price on Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th. Finally, Truist Financial lowered their price objective on Progyny from $33.00 to $26.00 and set a “buy” rating for the company in a research report on Thursday, September 19th. Seven analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, Progyny has an average rating of “Hold” and a consensus target price of $27.73.

Progyny Trading Up 0.7 %

Shares of Progyny stock opened at $17.18 on Wednesday. The firm has a market capitalization of $1.55 billion, a P/E ratio of 27.27, a P/E/G ratio of 1.61 and a beta of 1.44. Progyny has a 12 month low of $13.93 and a 12 month high of $42.08. The business has a fifty day simple moving average of $17.88 and a two-hundred day simple moving average of $23.62.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.